Gerresheimer (Düsseldorf / Germany; www.gerresheimer.com) is to invest EUR 12m to expand production of plastic systems for pharmaceutical, diagnostics and medical technology applications at its plant in Horsovsky Tyn / Czech Republic. The production area will double in size to around 10,000 m², with an increase in the workforce from the current 375 to around 450. Work is expected to be completed by the end of the current financial year.

The company said it intends to continue extending its share of the market for the treatment of chronic illnesses such as diabetes and asthma with its medical plastic systems for diagnostics and for the application of medications. “Our Czech plant will play a crucial role in this process because it’s one of our most modern medical plastic systems production facilities,” said Uwe Röhrhoff, Gerresheimer CEO.

The plastic systems division is now one of the company’s fastest-growing divisions, producing insulin pens for diabetics, inhalers for asthma sufferers, lancing devices and laboratory disposables for pharma, diagnostics and medical technology corporations.